PubMed=1701342
Nistico P., Tecce R., Giacomini P., Cavallari A., D'Agnano I., Fisher P.B., Natali P.G.
Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Cancer Res. 50:7422-7429(1990)

PubMed=1706743; DOI=10.1111/1523-1747.ep12470092
Cuomo M., Nicotra M.R., Apollonj C., Fraioli R., Giacomini P., Natali P.G.
Production and characterization of the murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope.
J. Invest. Dermatol. 96:446-451(1991)

PubMed=11266471; DOI=10.1083/jcb.152.4.809
Raposo G., Tenza D., Murphy D.M., Berson J.F., Marks M.S.
Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells.
J. Cell Biol. 152:809-824(2001)

PubMed=12417263; DOI=10.1016/S0006-2952(02)01353-9
De Marco F., Perluigi M., Marcante M.L., Coccia R., Foppoli C., Blarzino C., Rosei M.A.
Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells.
Biochem. Pharmacol. 64:1503-1512(2002)

PubMed=25950383; DOI=10.1111/pcmr.12380
Lazar I., Clement E., Ducoux-Petit M., Denat L., Soldan V., Dauvillier S., Balor S., Burlet-Schiltz O., Larue L., Muller C., Nieto L.
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 28:464-475(2015)

PubMed=28940687; DOI=10.1111/1348-0421.12542
Sato K., Watanabe O., Ohmiya S., Chiba F., Suzuki A., Okamoto M., Younghuang J., Hata A., Nonaka H., Kitaoka S., Nagai Y., Kawamura K., Hayashi M., Kumaki S., Suzuki T., Kawakami K., Nishimura H.
Efficient isolation of human metapneumovirus using MNT-1, a human malignant melanoma cell line with early and distinct cytopathic effects.
Microbiol. Immunol. 61:497-506(2017)